children
METHODS: Seventeen children with moderate asthma (aged       between 6 and 13 years, mean 8.76 years) received salmeterol with a spacer device       (Volumatic 200 micrograms daily, b.i.d.) for 3 weeks.
METHODS: Seventeen  @SUBJECT$  with moderate asthma (aged       between 6 and 13 years, mean 8.76 years) received salmeterol  @PREDICAT$  a  @OBJECT$        (Volumatic 200 micrograms daily, b.i.d.) for 3 weeks.